Article citationsMore>>

Wheeler, D.C., Jongs, N., Stefansson, B.V., Chertow, G.M., Greene, T., Hou, F.F., et al. (2021) Safety and Efficacy of Dapagliflozin in Patients with Focal Segmental Glomerulosclerosis: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) Trial. Nephrology Dialysis Transplantation, 37, 1647-1656.
https://doi.org/10.1093/ndt/gfab335

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top